Congenital malformations and maternal use of anti-hypertensive medication in the United Kingdom

Trial Identifier:	D2452R00003
Sponsor:	AstraZeneca
NCTID::	NCT02459990
Start Date:	June 2015
Primary Completion Date:	June 2015
Study Completion Date:	June 2015
Condition:	Hypertension

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.